Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.

Kaneko J, Kanazawa N, Tominaga N, Kaneko A, Suga H, Usui R, Ishima D, Kitamura E, Akutsu T, Yoshida K, Nishiyama K, Iizuka T.

J Neurol Sci. 2018 Jul 15;390:26-32. doi: 10.1016/j.jns.2018.04.009. Epub 2018 Apr 8.

PMID:
29801900
2.

Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis.

Kaneko A, Kaneko J, Tominaga N, Kanazawa N, Hattori K, Ugawa Y, Moriya A, Kuzume D, Ishima D, Kitamura E, Nishiyama K, Iizuka T.

J Neurol. 2018 Mar;265(3):586-596. doi: 10.1007/s00415-018-8749-3. Epub 2018 Jan 22.

PMID:
29356973
3.

Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy.

Iizuka T, Kanazawa N, Kaneko J, Tominaga N, Nonoda Y, Hara A, Onozawa Y, Asari H, Hata T, Kaneko J, Yoshida K, Sugiura Y, Ugawa Y, Watanabe M, Tomita H, Kosakai A, Kaneko A, Ishima D, Kitamura E, Nishiyama K.

Neurol Neuroimmunol Neuroinflamm. 2017 Sep 25;4(6):e396. doi: 10.1212/NXI.0000000000000396. eCollection 2017 Nov.

4.

Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Iizuka T, Kaneko J, Tominaga N, Someko H, Nakamura M, Ishima D, Kitamura E, Masuda R, Oguni E, Yanagisawa T, Kanazawa N, Dalmau J, Nishiyama K.

JAMA Neurol. 2016 Jun 1;73(6):706-13. doi: 10.1001/jamaneurol.2016.0232.

5.

[Clinical spectrum and treatment strategy in anti-NMDA receptor encephalitis: current status and issues].

Iizuka T, Ishima D, Kaneko J, Nishiyama K.

Rinsho Shinkeigaku. 2014;54(12):1098-102. doi: 10.5692/clinicalneurol.54.1098. Japanese.

PMID:
25672719

Supplemental Content

Loading ...
Support Center